AI
Friday, October 15, 2010 4:41:12 PM
DD -NVS might launch at-risk prior to a decision by the appellate court
Dew - would it be possible for MNTA/NVS to launch generic COPAXONE - at-risk without FDA approval? Can U state the pros/cons of such plus your likely percentages of each? T.I.A.
If so, I have a gut feeling that this might happen soon - quite possibly before the 3Q CC. No bets please
Dew - would it be possible for MNTA/NVS to launch generic COPAXONE - at-risk without FDA approval? Can U state the pros/cons of such plus your likely percentages of each? T.I.A.
If so, I have a gut feeling that this might happen soon - quite possibly before the 3Q CC. No bets please
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
